Zobrazeno 1 - 10
of 50
pro vyhledávání: '"Yan Hong Deng"'
Autor:
Swee Sung Soon, Whay-Kuang Chia, Mun-ling Sarah Chan, Gwo Fuang Ho, Xiao Jian, Yan Hong Deng, Chuen-Seng Tan, Atul Sharma, Eva Segelov, Shaesta Mehta, Raghib Ali, Han-Chong Toh, Hwee-Lin Wee
Publikováno v:
PLoS ONE, Vol 9, Iss 9, p e107866 (2014)
Recent observational studies showed that post-operative aspirin use reduces cancer relapse and death in the earliest stages of colorectal cancer. We sought to evaluate the cost-effectiveness of aspirin as an adjuvant therapy in Stage I and II colorec
Externí odkaz:
https://doaj.org/article/bf706f0459944a6ba39222a0ad9b6251
Autor:
De‐shen Wang, Zhi‐qiang Wang, Gong Chen, Jie‐wen Peng, Wei Wang, Yan‐hong Deng, Feng‐hua Wang, Jian‐wei Zhang, Han‐lin Liang, Fen Feng, Chuan‐bo Xie, Chao Ren, Ying Jin, Si‐mei Shi, Wen‐hua Fan, Zhen‐hai Lu, Pei‐rong Ding, Feng Wang, Rui‐hua Xu, Yu‐hong Li
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 151-159 (2020)
Abstract Background Monosialotetrahexosylganglioside (GM1) is a neuroprotective glycosphingolipid that repairs nerves. Oxaliplatin‐based chemotherapy is neurotoxic. This study assessed the efficacy of GM1 for preventing oxaliplatin‐induced periph
Externí odkaz:
https://doaj.org/article/682ecd5165c944018af40436d7288bb8
Autor:
Rui-Hua Xu, Lin Shen, Jin Li, Jian-Ming Xu, Feng Bi, Yi Ba, Li Bai, Yong-Qian Shu, Tian-Shu Liu, Yu-Hong Li, Chun-Mei Bai, Xiang-Lin Yuan, Jun Zhang, Gong Chen, Ai-Ping Zhou, Ying Yuan, Xi-Jing Wang, Xiao-Ping Qian, Yan-Hong Deng
Publikováno v:
Chinese Journal of Cancer, Vol 35, Iss 1, Pp 1-6 (2016)
Abstract The impact of maintenance therapy on progression-free survival and overall survival as well as quality of life of Chinese patients with metastatic colorectal cancer has long been under discussion. Recently, some phase III clinical trials hav
Externí odkaz:
https://doaj.org/article/e53c987c9f0b45d0bc0469b5febc6796
Autor:
Zhi-Qiang Wang, Dong-Sheng Zhang, Nong Xu, De-Yun Luo, Yan-Hong Deng, Feng-Hua Wang, Hui-Yan Luo, Miao-Zhen Qiu, Yu-Hong Li, Rui-Hua Xu
Publikováno v:
Chinese Journal of Cancer, Vol 35, Iss 1, Pp 1-7 (2016)
Abstract Background Fluoropyrimidine and oxaliplatin are widely used for patients with colorectal cancer. This phase II study was conducted to evaluate the efficacy and safety of the combination of S-1, oxaliplatin, and leucovorin (SOL) in the treatm
Externí odkaz:
https://doaj.org/article/41848663e2764de0b58a1693aa362e52
Publikováno v:
World Journal of Clinical Cases
BACKGROUND The brain is the most complex organ in the human body. Treatment for a glioma always involves a multi-disciplinary team. Nursing care in fast-track surgery or enhanced recovery after surgery is such kind of work implemented by an interdisc
Autor:
Fen Feng, Yu Hong Li, Wen hua Fan, Wei Wang, Zhen Hai Lu, Feng Wang, Rui-Hua Xu, Si mei Shi, Ying Jin, Zhi Qiang Wang, Feng Hua Wang, Pei-Rong Ding, Han lin Liang, De Shen Wang, Gong Chen, Yan Hong Deng, Chao Ren, Chuan bo Xie, Jianwei Zhang, Jie wen Peng
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 151-159 (2020)
Cancer Medicine
Cancer Medicine
Background Monosialotetrahexosylganglioside (GM1) is a neuroprotective glycosphingolipid that repairs nerves. Oxaliplatin‐based chemotherapy is neurotoxic. This study assessed the efficacy of GM1 for preventing oxaliplatin‐induced peripheral neur
Autor:
Yan-Hong Deng, Hong Ren, Shuang Xiao, Neng Shen, Huadong Tang, Peng Hu, Mingli Peng, Yong Sun
Publikováno v:
International immunopharmacology. 101
Our previous studies demonstrated that Curc-mPEG454, a curcumin derivative modified with short-chain polyethylene glycol (PEG), not only increased the blood concentration of curcumin, but also retained its anti-inflammatory activity. Here, we aimed t
Autor:
Feng, Wang, Tian-Shu, Liu, Xiang-Lin, Yuan, Hui-Yan, Luo, Kang-Sheng, Gu, Ying, Yuan, Yan-Hong, Deng, Jian-Ming, Xu, Yu-Xian, Bai, Ying, Wang, Wang-Jun, Liao, He-Long, Zhang, Feng, Bi, Bang-Mao, Wang, Zhi-Xiang, Zhuang, Teng-Jia, Jiang, Rui-Hua, Xu
Publikováno v:
Am J Cancer Res
Gastric cancer (GC) is the second most common cancer in China. The ToGA study showed that trastuzumab in combination with fluoropyrimidine plus cisplatin prolonged overall survival (OS) in patients with human epidermal growth factor receptor 2 (HER2)
Autor:
Hiroshi Matsuoka, Yi Ba, Wei Wang, Young Suk Park, Satoshi Morita, Junichi Sakamoto, Masahito Kotaka, Joong Bae Ahn, Tae Won Kim, Rui-Hua Xu, Sae-Won Han, Keun Wook Lee, Masato Nakamura, Yan Hong Deng, Tao Zhang, Sang-Hee Cho, Yasuhide Yamada, Takeshi Kato, Satoru Iwasa, Kei Muro
Publikováno v:
The Lancet Oncology. 19:660-671
Summary Background Studies of a modified XELIRI (mXELIRI; capecitabine plus irinotecan) regimen suggest promising efficacy and tolerability profiles in the first-line and second-line settings. Therefore, we aimed to compare the efficacy and safety of
Autor:
Jinjiang Wang, Qingdong Ou, Jian-Xin Tang, Liezun Chen, Dengyu Zhang, Yan-Hong Deng, Yan-Qing Li
Publikováno v:
Organic Electronics. 51:452-457
An intermediate connector of Cs 2 CO 3 /Al/MoO 3 used in tandem organic light-emitting diodes (OLEDs) was investigated in this work. Here, an ultrathin Cs 2 CO 3 /Al was used as an electron-injection layer (EIL) from MoO 3 to the adjacent electron tr